Research Projects

Research Projects

2025-28

Title: An alternative novel approach to antibody-based therapy for tumour necrosis factor alpha (TNF-alpha) inhibition: a therapeutic sortase enzyme developed through protein engineering.

Funding entity: The Scientific and Technological Research Council of Turkey (Turkish: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, TÜBİTAK)

Duration (months): 36

Date: from 10/04/2025 to 09/03/2028

2024-27

Title: Personalised medicine through the application of targeted gene therapy for the improvement of diagnosis and treatment of Osteogenesis Imperfecta.

Funding entity: 21st Call for Healthcare Research Grants from the Mutua Madrileña Foundation

Duration (months): 36

Date: from 01/10/2024 to 30/09/2027

2024-26

Title: Advancing the understanding of CHAR syndrome: genotype-phenotype correlation.

Funding entity: Ernesto Sánchez Villares Foundation

Duration (months): 18

Date: from 18/06/2024 to 17/01/2026

2024-26

Title: Integractomics: Integration of multi-omics and imaging data through the application of Artificial Intelligence algorithms for the diagnosis and identification of molecular pathways involved in the development of Rare Diseases.

Funding entity: Foundation for Biosanitary Research of Eastern Andalusia – Alejandro Otero (FIBAO)

Duration (months): 36

Date: from 01/01/2024 to 31/12/2026

2023

Title: Molecular bases and functional consequences of germline variants in RASopathy-causing genes as predictors of clinical outcomes in paediatric populations

Funding entity: Regional Health Management of Castilla y León

Duration (months): 12

Date: from 19/04/2023 to 31/12/2023

2021-23

Title: Molecular Genetics and Its Relationship with Neurological Alterations in Paediatric Patients Affected by Rasopathy.

Funding entity: Alicia Koplowitz Foundation

Duration (months): 24

Date: from 01/11/2021 to 31/10/2023

2021-23

Title: RASopathies, Molecular Genetics, and Their Relationship with Endocrinological and Anthropometric Alterations in Patients from Castilla y León.

Funding entity: Spanish Society of Paediatric Endocrinology

Duration (months): 24

Date: from 01/07/2021 to 30/06/2023

2021

Title: Bioinformatic analysis and molecular characterisation of a pathogenic variant in the gene SPRED1 Causative of Legius syndrome.

Funding entity: University of Salamanca

Duration (months): 11

Date: from 01/02/2021 to 31/12/2021

2020

Title: Precision personalised medicine for patients diagnosed with Rare Diseases in Castilla y León. Molecular basis of genotypic variability in neurofibromatosis type 1 (NF1) and related syndromes.

Funding entity: SACYL. Regional Health Management.

Duration (months): 12

Date: from 01/10/2019 to 31/12/2020

Support Research

Every donation is a beacon of hope in advancing research into rare diseases. With your support and the power of science, we can deliver meaningful solutions.

donación.girber

Contact us

If you are interested in collaborating with our research group, we invite you to get in touch. Please complete the form so we can explore new research opportunities together.

Contact Form

13 + 8 =

en_GB